摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(cyclopent-1-en-1-yl)-1H-pyrazole | 18714-88-0

中文名称
——
中文别名
——
英文名称
3-(cyclopent-1-en-1-yl)-1H-pyrazole
英文别名
3-pyrazol;3-cyclopent-1-enyl-1(2)H-pyrazole;5-(cyclopenten-1-yl)-1H-pyrazole
3-(cyclopent-1-en-1-yl)-1H-pyrazole化学式
CAS
18714-88-0
化学式
C8H10N2
mdl
——
分子量
134.181
InChiKey
JGHMMIULJFZDBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.98
  • 重原子数:
    10.0
  • 可旋转键数:
    1.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    28.68
  • 氢给体数:
    1.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    5-chloro-7-morpholino-2-(pyridin-2-yl)furo[3,2-b]pyridine 、 3-(cyclopent-1-en-1-yl)-1H-pyrazoletris-(dibenzylideneacetone)dipalladium(0)caesium carbonate 、 ditert-butyl-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane-2-phenylethanamine chloropalladium(1+) 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 150.0 ℃ 、101.33 kPa 条件下, 以10 mg的产率得到5-(3-(cyclopent-1-en-1-yl)-1H-pyrazol-1-yl)-7-morpholino-2-(pyridin-2-yl)furo[3,2-b]pyridine
    参考文献:
    名称:
    [EN] 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    [FR] DÉRIVÉS DE 7-MORPHOLINO-5-(3-PHÉNYL-1H-PYRAZOL-1-YL)-FURO[3,2-B]PYRIDINE ET COMPOSÉS SIMILAIRES SERVANT D'INHIBITEURS DE LA PIKFYVE KINASE POUR LE TRAITEMENT PAR EXEMPLE, DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE (ALS)
    摘要:
    The present invention relates to compounds of formula (I) that are inhibitors of PlKfyve kinase and are therefore useful for the treatment of e.g. neurological diseases, such as e.g. amyotrophic lateral sclerosis (ALS), Parkinson's disease, Alzheimer's disease, Huntington's disease, ADHD, schizophrenia, depression, or bipolar disorder. An exemplary compound is e.g. 7-morpholino-5-(3-phenyl-lH- pyrazol-l-yl)-2-(lH-pyrazol-4-yl)furo[3, 2-b]pyridine (compound 10) Data on the PlKfyve kinase inhibition are provided, e.g.:
    公开号:
    WO2022256299A1
  • 作为产物:
    描述:
    3-(cyclopent-1-en-1-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 以45 mg的产率得到3-(cyclopent-1-en-1-yl)-1H-pyrazole
    参考文献:
    名称:
    [EN] 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    [FR] DÉRIVÉS DE 7-MORPHOLINO-5-(3-PHÉNYL-1H-PYRAZOL-1-YL)-FURO[3,2-B]PYRIDINE ET COMPOSÉS SIMILAIRES SERVANT D'INHIBITEURS DE LA PIKFYVE KINASE POUR LE TRAITEMENT PAR EXEMPLE, DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE (ALS)
    摘要:
    The present invention relates to compounds of formula (I) that are inhibitors of PlKfyve kinase and are therefore useful for the treatment of e.g. neurological diseases, such as e.g. amyotrophic lateral sclerosis (ALS), Parkinson's disease, Alzheimer's disease, Huntington's disease, ADHD, schizophrenia, depression, or bipolar disorder. An exemplary compound is e.g. 7-morpholino-5-(3-phenyl-lH- pyrazol-l-yl)-2-(lH-pyrazol-4-yl)furo[3, 2-b]pyridine (compound 10) Data on the PlKfyve kinase inhibition are provided, e.g.:
    公开号:
    WO2022256299A1
点击查看最新优质反应信息